| Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin K Hou, J Shen, J Yan, C Zhai, J Zhang, JA Pan, Y Zhang, Y Jiang, Y Wang, ... EBioMedicine 69, 2021 | 102 | 2021 |
| The ubiquitin E3 ligase TRIM21 promotes hepatocarcinogenesis by suppressing the p62-Keap1-Nrf2 antioxidant pathway F Wang, Y Zhang, J Shen, B Yang, W Dai, J Yan, S Maimouni, ... Cellular and molecular gastroenterology and hepatology 11 (5), 1369-1385, 2021 | 56 | 2021 |
| Glutamine synthetase limits β-catenin–mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1 W Dai, J Shen, J Yan, AJ Bott, S Maimouni, HQ Daguplo, Y Wang, ... The Journal of clinical investigation 132 (24), 2022 | 34 | 2022 |
| Abstract PO-019: Ubiquitin E3 ligase OSTM1 regulates the cAMP/PKA/CREB pathway and suppresses B-cell malignancies MU Tariq, J Shen, J Jung, N Sheshadri, J Yan, R Li, K Lu, T Liu, H Li, ... Blood Cancer Discovery 5 (3_Supplement), PO-019-PO-019, 2024 | | 2024 |
| Abstract PO-035: Genome-wide CRISPR knockout screen identifies sialylation as a tumor suppressive mechanism in B-cell malignancies N Sheshadri, R Li, MU Tariq, J Shen, J Jung, J Yan, K Lu, Z Shen, P Xie, ... Blood Cancer Discovery 5 (3_Supplement), PO-035-PO-035, 2024 | | 2024 |
| Abstract PO-020: ZBTB24 is a novel tumor suppressor and cooperates with CDKN2A to suppress B-cell lymphomagenesis R Li, N Sheshadri, J Shen, J Yan, J Jung, MU Tariq, YL Wang, P Xie, ... Blood Cancer Discovery 5 (3_Supplement), PO-020-PO-020, 2024 | | 2024 |
| Hepatic regulation of nitrogen metabolism by β-catenin J Yan, WX Zong Tristate Cancer Metabolism Meeting, 2023 | | 2023 |
| Arginine metabolism confers metabolic vulnerability in PDAC J Yan, S Maimouni, HQ Daguplo, J Shen, E Chiles, LT Healy, YJ Yoo, ... The 2022 Annual Retreat on Cancer Research in New Jersey, 2022 | | 2022 |
